申请人:Telik, Inc.
公开号:US06653321B1
公开(公告)日:2003-11-25
Methods for treating conditions associated with hyperglycemia, especially Type II diabetes, with novel naphthylsulfonic acids and related compounds. These compounds, as single stereoisomers or mixtures of stereoisomers, or their pharmaceutically acceptable salts, are useful in methods of stimulating the kinase activity of the insulin receptor, enhancing the activation of the insulin receptor by insulin, and stimulating the uptake of glucose into cells. A variety of antidiabetic compounds and pharmaceutical compositions comprising the antidiabetic compounds are also disclosed.
使用新型萘磺酸和相关化合物治疗与高血糖相关的疾病,特别是II型糖尿病的方法。这些化合物,作为单一立体异构体或立体异构体混合物,或它们的药用可接受盐,在刺激胰岛素受体的激酶活性、增强胰岛素对胰岛素受体的激活以及促进葡萄糖进入细胞的方法中具有用途。还披露了各种抗糖尿病化合物和包含这些抗糖尿病化合物的药物组合物。